Intracardiac Flow Assessment in Cardiac Amyloidosis

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT05379101
Status
Recruiting

Conditions

  • Amyloidosis Cardiac
  • Healthy Adults

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Cardiac magnetic resonance image (CMR) — DIAGNOSTIC_TEST
    A magnetic resonance imaging study for assessment of cardiac structure and intracardiac flow
  • Transthoracic Echocardiogram (TTE) — DIAGNOSTIC_TEST
    An imaging test that uses soundwaves that cannot be heard (ultrasound) to take pictures of the heart and vessels.
  • Six-minute Walk Test — DIAGNOSTIC_TEST
    A self-paced, test of exercise capacity performed unencouraged intensity that measures the distance that patients can walk on a flat, hard surface in a period of 6 minutes

Study Details

The primary objective of this study is to define the intracardiac flow imaging biomarkers in cardiac amyloidosis.

Key Dates

Start date
Jul 20, 2022
Status verified
Jul 2025
Primary completion
May 31, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Transthyretin (ATTR) cardiac amyloidosis
    Subjects diagnosed with ATTR cardiac amyloidosis will have CMR, TTE, and 6-minute walk
  • Arm: Light chain amyloidosis (AL) with cardiac involvement
    Subjects diagnosed with AL with cardiac involvement will have CMR, TTE, and 6-minute walk
  • Arm: Light chain amyloidosis (AL) without cardiac involvement
    Subjects diagnosed with AL without cardiac involvement will have CMR, TTE, and 6-minute walk
  • Arm: Healthy Control
    Subjects without history of cardiovascular diseases will have CMR, TTE, and 6-minute walk

Primary Outcome Measure

Define the intracardiac flow imaging biomarkers in cardiac amyloidosis (CA) [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Kathy Brown
507-538-1321
Ian C Chang, MD (PRINCIPAL_INVESTIGATOR)
Christopher Francois, MD (SUB_INVESTIGATOR)

Find similar trials in Rochester, MN

Related Studies